Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• The emergence of SARS-CoV-2 has led to a global pandemic, necessitating rapid development of effective vaccines.
• Extensive global scientific efforts are underway to identify and test various therapeutics and prophylactics against COVID-19.
• Understanding the landscape of vaccine development is crucial for combating the ongoing pandemic.

Purpose of the Study:

• To compile and analyze COVID-19 vaccines undergoing preclinical and clinical testing.
• To provide detailed information on vaccine technologies, trial designs, and clinical findings.
• To discuss challenges, safety concerns, and public responses related to COVID-19 vaccine trials.

Main Methods:

• Data compilation from the World Health Organization (WHO) and ClinicalTrials.gov databases.
• Systematic review of preclinical and clinical vaccine studies.
• In-depth analysis of the most advanced vaccine candidates, including their technological platforms.

Main Results:

• A comprehensive list of COVID-19 vaccines in various stages of development was created.
• Details on trial designs, locations, and recent clinical findings for advanced vaccines were summarized.
• Key advantages, disadvantages, challenges, and safety concerns associated with vaccine development were identified.

Conclusions:

• The COVID-19 vaccine landscape is complex, with diverse technologies and ongoing challenges.
• Continued monitoring and analysis of vaccine trials are essential for understanding progress and addressing concerns.
• The findings aim to enhance comprehension of the global effort to find a SARS-CoV-2 prophylactic.